Pharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort Study.

PLoS One · 2015 · PMC4669156 · PMID 26633885

Europe PMC DOI

hedged sentences

0.3320

closest p · 6.6× alpha

0.3320

boldest claim

The sentences

showed a trendP = 0.332not close (p > 0.1)

Accordingly, although there were overlapping CIs for hazard rate ratios, the difference in risk of CV death between ACEI-treated patients with ischemic versus non-ischemic CHF, showed a trend for increased risk of CV death with increasing score A in patients with ischemic CHF (P = 0.332 [ Fig 4 ]).

also in 53,322 other papers

of borderline significanceno p-value reported

Of note, the genotype frequency of rs495828 of ABO in our study population was not in Hardy-Weinberg equilibrium, but this aberration was only of borderline significance.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.